Print

Print


Dear Ben, Ash, Jon and colleagues

 

I would be interested in reviewing some case vignettes.  I fully support this recognition of the importance of type I and II cognitive systems in the papers by Ben, Jon and their colleagues.  I have been teaching something similar in the clinical setting when I call type I cognition 'Non transparent intuitive thinking' and type II 'transparent thinking'.  I suggest to students and trainees that one should be used as a check for the other and that when both lead to the same conclusion, then this should result in more accurate predictions of diagnostic and treatment outcomes (see pages 4 to 13 and page 17 of the attached chapter 1 of the Oxford Handbook of Clinical Diagnosis).

 

With best wishes

 

Huw


From: Evidence based health (EBH) [[log in to unmask]] on behalf of Djulbegovic, Benjamin [[log in to unmask]]
Sent: 15 September 2012 12:16
To: [log in to unmask]
Subject: Re: How Clinical Decisions are Made

 

Dear Ash & Jon,

Thanks for noticing our article. Unfortunately, the provision PDF version currently on the web contains some typos including display of Fig 4 (this should be corrected in the final version of the paper, due to be posted any day now). The meat of the paper is in Fig 4, the correct version copied here:

 

 

 

Fig displays the threshold probability as a function of benefit/harms ratio as derived by cognitive system II (EUT or EBM approach) (solid line). The treatment should be given if the probability of disease is above the threshold, otherwise it should be withheld. Note that if cognitive system I perceives that harms are higher than system I benefits (BI < HI), the threshold probability is ALWAYS higher than the EBM threshold (dotted line). However, if BI > HI, the threshold probability is ALWAYS lower than the EBM threshold (dashed line).

We thinks this can explain variation in practice, particularly when physicians try to apply research evidence (from the group of patients) to individual patients. We have also developed a model that takes a diagnostic test into consideration (the paper is being written as we speak).

We are currently trying to empirically test our model (using vignette-based approach). If any of the Group’s practicing physicians is intrerested in reviewing a couple of case vignettes, please contact me.

Thank you all

ben

 

From: Evidence based health (EBH) [mailto:[log in to unmask]] On Behalf Of Ash Paul
Sent: Saturday, September 15, 2012 5:24 AM
To: [log in to unmask]
Subject: Re: How Clinical Decisions are Made

 

Dear colleagues,

Jon Brassey from our Group has also pointed out to me that yet another member of our Group Ben Djulbegovic has also published a similar related article very recently (many thanks Jon!) in BMC Medical Informatics:

Dual processing model of medical decision-making

Regards,

Ash


 

From: Ash Paul
Sent: 15/09/2012 09:31
To: [log in to unmask]
Subject: Re: How Clinical Decisions are Made


 

 

Dear colleagues,

FYI (an excellent article by Neal Maskrey, Andy Hutchinson and Jonathan Underhill, all members of our Group, writing in the British Journal of Clinical Pharmacology)

Regards,

 

 

Ash

Dr Ash Paul

Medical Director, East of England SCG

Midlands and East Specialised Commissioning Group (East of England Office)

Endeavour House, Cooper's End Road

Stansted CM24 1SJ

(: 01279666300

È: 01279210740